See All Slides - tctmd.com

Slides

Presentation ACC 2012

Biodegradable Polymer Drug-Eluting Stents Versus Durable Polymer Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

Presenter: Robert A. Byrne

March 24, 2012

Presentation PCI Outcomes 2012

Controversy 3: In an Era of Increasing Governmental and Payer Oversight, Who Is Appropriate (and Not Appropriate) for PCI?

Presenter: Manesh R. Patel

March 23, 2012

Presentation PCI Outcomes 2012

Case 3: A Patient with Recurrent Stent Thrombosis

Presenter: Roxana Mehran

March 23, 2012

Presentation

Stent Thrombosis with DES and BMS

Presenter: T. Palmerini

March 23, 2012

Presentation PCI Outcomes 2012

Procedural Guidance with FFR

Presenter: William F. Fearon

March 23, 2012

Presentation PCI Outcomes 2012

Controversy 2, Part A: The Case for Surgery in Patients with Complex Coronary Artery Disease

Presenter: Patrick W. Serruys

March 23, 2012

Presentation PCI Outcomes 2012

Prevention and Treatment of Stent Thrombosis

Presenter: Ajay J. Kirtane

March 23, 2012

Presentation PCI Outcomes 2012

My Fellow's Worst Complication

Presenter: Paul S. Teirstein

March 23, 2012

Presentation PCI Outcomes 2012

Optimizing Stent Selection (A Patient- and Lesion-Specific Approach)

Presenter: Martin B. Leon

March 23, 2012

Presentation PCI Outcomes 2012

Controversy 2, Part B: The Case for PCI in Patients with Complex Coronary Artery Disease

Presenter: Antonio Colombo

March 23, 2012

Advertisement

Slides

Biodegradable Polymer Drug-Eluting Stents Versus Durable Polymer Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

Controversy 3: In an Era of Increasing Governmental and Payer Oversight, Who Is Appropriate (and Not Appropriate) for PCI?

Case 3: A Patient with Recurrent Stent Thrombosis

Stent Thrombosis with DES and BMS

Procedural Guidance with FFR

Controversy 2, Part A: The Case for Surgery in Patients with Complex Coronary Artery Disease

Prevention and Treatment of Stent Thrombosis

My Fellow's Worst Complication

Optimizing Stent Selection (A Patient- and Lesion-Specific Approach)

Controversy 2, Part B: The Case for PCI in Patients with Complex Coronary Artery Disease

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content